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Tributyltin (TBT) is one of the most toxic compounds produced by man and distributed in the environment. A multitude of
toxic activities have been described, for example, immunotoxic, neurotoxic, and endocrine disruptive eﬀects. Moreover, it has
been shown for many cell types that they undergo apoptosis after treatment with TBT and the cell death of immune cells could
be the molecular background of its immunotoxic eﬀect. As low as 200nM up to 1μM of TBT induces all signs of apoptosis in
Jurkat T cells within 1 to 24 hrs of treatment. When compared to Fas-ligand control stimulation, the same sequence of events
occurs: membrane blebbing, phosphatidylserine externalisation, the activation of the “death-inducing signalling complex,” and
the following sequence of cleavage processes. In genetically modiﬁed caspase-8-deﬁcient Jurkat cells, the apoptotic eﬀects are only
slightly reduced, whereas, in FADD-negative Jurkat cells, the TBT eﬀect is signiﬁcantly diminished. We could show that caspase-10
is recruited by the TRAIL-R2 receptor and apoptosis is totally prevented when caspase-10 is speciﬁcally inhibited in all three cell
lines.
1.Introduction
Tributyltin (TBT) is one of the most toxic compounds still
used in antifouling paints for large commercial ships thereby
distributed within the aquatic environment. Its distribution
andaccumulationinaquaticorganismsleadstosevereeﬀects
and has already reduced the number of snail species in the
near of sea lanes and harbours [1]. Moreover, the trophic
transfer has been demonstrated [2], and the accumulation
within the food chain up to the level of marine mammals
has reached concentrations that might be biological relevant
[3–6]. The most prominent biological eﬀect investigated so
far is the so-called imposex within sea snails and dogwhelks
[1, 7, 8], and this mechanism is used as biomonitoring tool
for organotin compounds [9]. Despite the fact that a lot
of studies have been carried out, the underlying molecular
mechanism remains unclear [10, 11]. It has been proposed
that the inhibition of aromatase activity alters the ratio of
the hormones inducing the development of imposex, the
imposition of male sex characteristics on female snails [1,
12], but other studies came to other results [11, 13].
As organotin compounds were still used and accumulate
in the environment as well as in the food chain, the exposure
of mammals and humans increases steadily. Moreover, it has
been described earlier that organotin compounds, especially
TBT, have a clear immunotoxic eﬀect in mammals [14–
16], and this might be due to their exorbitant induction of
apoptosis [17, 18]. The eﬀective concentration of TBT to
induce apoptosis in the majority of treated cells is around or
below 1μM and has been shown in vitro [14, 18–27]a sw e l l
as in vivo [28, 29]. The question whether the disturbance of
the intracellular calcium homeostasis is responsible for the
onset of apoptosis [22, 27, 30–34] or the direct eﬀect on
mitochondrial functions is the ﬁrst event [18, 20, 24, 32, 33,
35] is under discussion for a long time. Stridh et al. [18, 23]
have shown a decade ago that TBT induces apoptosis via the
activation of caspases in various human cells, the link for
this caspase activation was not yet found. The most obvious
players have been discussed to be the increase in calcium
concentration or the opening of the permeability pore of
the mitochondria. But induction of apoptosis has been
demonstrated for very low concentrations of TBT which2 Journal of Toxicology
do not induce calcium inﬂux [27], and caspases are often
inhibited by high calcium concentrations [23]. Some years
ago, evidence arose that mitochondria-independent mech-
anisms contribute to the induction of apoptosis and possibly
death receptors or direct caspase activation are involved in
the TBT induced eﬀect [36–39].
It is now generally accepted that the programmed cell
death can be physiologically induced via death receptors on
the surface of the cells, activated by speciﬁc ligands that are
strictly controlled for instance during development or in-
ﬂammation [40] leading to the formation of the so-called
“death-inducing signalling complex” or DISC [41]. More-
over, it has been shown that at least lymphoid cells can be
discriminated into type I and type II cells and only type
II cells are strongly dependent on functional mitochondria
for their apoptotic machinery [42]. Jurkat T-lymphoblastoid
cells are type II cells and present a special tool for the investi-
gationofmitochondrial-dependentcelldeathcharacteristics.
Additionally, genetic modiﬁcations of the DISC within these
cells enable a closer look at which point the sequence of
events is started after TBT-treatment.
In the present study, the mechanism of TBT-induced
apoptosis has been investigated by the use of Jurkat T-
cells and two variants, caspase-8 and FADD-deﬁcient Jurkat
cells, that provide a direct insight into the death-receptor-
coupled mechanisms. The data presented here point to the
involvement of initiator caspase activation, especially from
caspase-10, and are discussed in terms of the potential
immunotoxic role of TBT in exposed mammals.
2. Results
2.1. TBT Induces Apoptosis in Human Jurkat Cells. When
human immune cells were treated with TBT, changes of
morphological as well as biochemical parameters of apop-
tosis can be observed. In all experiments done in this study,
we used 1μM TBT, a concentration that induces apoptosis
in the majority of the treated cells within 4 hours. After
that, time membrane blebbing and the externalisation of
phosphatidylserine (PS) occur and chromatin condensation
could be observed in Jurkat A3 T-cells (Figures 1(a) and
1(b)). Chromatin condensation was shown by the use of the
DNA dye Hoechst 33342, and PS on the outer leaﬂet of the
plasma membrane is detected with Annexin V-FITC by ﬂow
cytometry (FACS) and ﬂuorescence microscopy (Figures
1(c)–1(h)). As demonstrated by two typical FACS dot blots,
more than 60% of the treated cells undergo apoptosis and
exhibit green ﬂuorescence at the plasma membrane without
being necrotic as the counter staining with propidium
iodide demonstrates clearly. Looking closer to the diﬀerent
proteins that are involved in the apoptotic machinery, the
complete sequence of events from initiator caspases down
to death substrates is switched on. Focussing at the level
of initiator caspases, both, caspase-8 and caspase-10, are
cleaved and their active subunits can be detected by western
blotting (Figure 1, left). Downstream the initiator caspases,
the BID protein is an important linker to the mitochondrial
pathway in type II cells and this protein is cleaved after TBT
treatment. From the multitude of caspases downstream of
the mitochondria we tested for procaspase-9, -7, -6, and -3
and found all these proteases cleaved. As one of the most
prominent death substrates poly(ADP-ribose) polymerase
(PARP) has also been shown to be cleaved within this series
of events (Figure 1, left). Moreover, we tested hepatocytes
transfected with a fusion protein of cytochrome c/green
ﬂuorescent protein (kindly provided by D. Green, La Jolla
Institute for Allergy and Immunology, San Diego, USA) and
found the release of cytochrome c after TBT treatment (data
not shown).
2.2. Apoptosis Is Diminished in Deﬁcient Cell Lines and De-
pendent from Caspase Activity. The extrinsic pathway
upstream the mitochondria is further characterised by use
of two genetically modiﬁed Jurkat cell lines where one is
caspase-8 deﬁcient and the other is FADD adaptor protein
deﬁcient. Furthermore, various caspase inhibitors were used
to dissect their roles as possible starting point of the apop-
totic sequence of events induced by TBT. Firstly, caspase-
8 deﬁcient cells exhibit only a slight reduction of apoptosis
in all three cell lines when incubated with 1 or 1.5μM
TBT (Figure 2), whereas Fas-ligand-induced apoptosis was
completely abolished (not shown). Without caspase-8, the
only measurable protection was found for PS externalisation
that is reduced by one third (Figure 3). Secondly, FADD
deﬁciency aﬀords an improved protection against the eﬀects
caused by TBT exposure, especially at lower concentrations
(Figure 2,1 μM TBT). This is further corroborated by
analysis of PS externalisation and the total caspase activity
by a ﬂuorescence assay in living cells. The externalisation of
PS was reduced in the same order of magnitude as in the
caspase-8-deﬁcient cells (Figure 3), but the CaspaTag assay
demonstrateshighproteaseactivityinTBT-treatedwild-type
cells as well as in the caspase-8-deﬁcient variant, whereas
in FADD-deﬁcient cells, this activity is obviously reduced
(Figure 4).
The importance of caspases for organotin-provoked
apoptosis has been investigated by use of several inhibitors.
The overall caspase inhibitor zVAD-fmk blocks totally all
described eﬀects that normally can be detected after TBT
exposure (data not shown). In this study, we used fur-
ther speciﬁc inhibitors of caspases downstream as well as
upstream of mitochondria. When caspase-9 and caspase-
3 were inhibited as most potent elements of the caspase
cascade downstream of the mitochondria, TBT-induced
apoptosis is fully prevented in all three cell lines (Figure 2).
PreincubationoftheJurkatcellswithzLEHD-fmk(caspase-9
inhibitor) and zDEVD-fmk (caspase-3 inhibitor) rescues all
viable functions. Nevertheless, a closer look at the western
blots revealed often a slight reduction of those elements
that were cleaved upstream of the mitochondria, especially
BID, even though at slightly higher concentrations of TBT
(Figure 2,1 . 5μM). While caspase-8 is activated in fact after
TBT treatment of wild-type Jurkat cells, caspase-8 deﬁcient
cells undergo apoptosis to a comparable extent. This result
suggests that caspase-8 cannot play a substantial role within
this concert of eﬀects after TBT treatment. Therefore, we
looked closer for caspase-10, the second initiator caspase at
the receptor level.Journal of Toxicology 3
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Figure 1: Induction of apoptosis in Jurkat T cells by TBT. Jurkat cells were treated with 1μM TBT or ethanol (control) for 4h before samples
were analysed. Nuclei of vehicle-treated control cells (a) and after TBT treatment (b) were stained with Hoechst 33342 and analysed with a
ﬂuorescence microscope. Both pictures show an overlay of diﬀerential interference contrast light microscopy pictures with the ﬂuorescence
pictures. From the same experiment, samples were stained with annexin V-FITC for phosphatidylserine externalisation (c–h). Control cells
were shown with DIC contrast (c), and no green ﬂuorescence could be detected at 525 ± 12.5nm (d). TBT-treated cells exhibit ruﬄed
membranes and granular cytoplasm (e) and strong PS-labelling at the plasma membrane (f). The annexin-positive cells were further
quantiﬁed by ﬂow cytometry. The quadrant analysis of double labelled cells is shown for control (g) and TBT-treated cells (h). 10000 cells
of each sample were counted, and the percentage of viable cells (lower left quadrant, grey dots), apoptotic cells (lower right, green dots), and
necrotic cells (upper two quadrants, red dots) were given in the dot blots. On the left side of the ﬁgure, immunoblots for 8 diﬀerent proteins
were shown. Protein names and molecular weights are given aside the blots. Left lane: control sample; right lane: TBT-treated sample.
2.3. Caspase-10 Is Obligatory for TBT-Induced Apoptosis,
and Its Inhibition Prevents Apoptosis. When caspase-10 is
inhibited by zAEVD-fmk, PS externalisation (Figure 3)a n d
overall caspase activity is drastically reduced in all cell lines
investigated in this study (Figure 4). Next, we wanted to
know if initiator caspases could be found in an activated
DISC and which ones. Immunoprecipitations (IP) with an
antibody against the Fas-receptor coprecipitated caspase-8
(data not shown), but this caspase has no substantial rel-
evance for the TBT eﬀect in Jurkat cells as shown above.
Therefore, we tested Jurkat cells for other death receptors
and found additionally TRAIL-R1, TRAIL-R2, TRAIL-R3,
TRAIL-R4, and TNF-R1. As TRAIL-R2 was the dominant
form and TRAIL-R3 and TRAIL-R4 are decoy receptors, we4 Journal of Toxicology
Figure 2: Inhibition of TBT-induced apoptosis by caspase-9 and
caspase-3 inhibitors. Western blots of 5 diﬀerent proteins in
Jurkat A3 parental and the two deﬁcient cell lines are shown.
Cells were treated with 1 or 1.5μM TBT for 4h before proteins
were separated on SDS-gels and immunoblotted. Another set of
samples was preincubated for 1h with the inhibitors for caspase-3
(DEVD,10μM)andcaspase-9(LEHD,30μM)beforeTBT(1μMor
1.5μM) was added. For molecular weights of proteins and cleavage
products, compare Figure 1.
used a TRAIL-R2 antibody for our IPs. With this antibody,
we could precipitate both initiator caspases after 3h of
treatment with 1μMT B T( Figure 5(a)). Additionally, we
detected the procaspases-8 and -10 in the untreated controls
but to a much lesser extent and we never found the activated
subunits. Analysing the three diﬀerent cell lines reveals the
fact that caspase-10 could be found in all activated DISC
forms even though at diﬀerent levels (Figure 5(b)).
2.4. Diﬀerent Roles of Caspase-8 and Caspase-10 in Fas-
Ligand and TBT-Induced Apoptosis. A direct comparison of
the eﬀects of Fas-ligand and TBT in all three cell lines pre-
treated with and without the caspase-10 inhibitor zAEVD-
fmk provides a detailed insight into the diﬀerent roles of the
two initiator caspases in human Jurkat T cells. Fas-ligand
treatment of the two deﬁcient cell lines has no eﬀect at all,
and, thus, these data were not included in Figure 6.T h e
Jurkat A3 wild-type cells, however, were driven into apopto-
sis,andthiseﬀectisonlytoaminordegreediminishedbythe
pretreatment with the caspase-10 inhibitor, and apoptosis
still proceeds. TBT treatment, however, has approximately
the same eﬀect as Fas-ligand in the absence of zAEVD-fmk,
but all consequences of this treatment were prevented in
the presence of AEVD. Phosphatidylserine externalisation is
reduced to nearly control levels (Figure 3), and activation
of caspases is strongly decreased in all three cell lines
(Figure 4). In addition, the cleavage of important caspases is
prevented (caspase-8 and caspase-3, Figure 6), BID cleavage
is drastically diminished, PARP is completely rescued, and
DNA fragmentation does not proceed anymore (Figure 6).
3. Discussion
Trialkylated tin compounds, especially TBT, are distributed
all over the environment, and were taken up by cells in vitro
fast and eﬀectively and their toxicity is a function of both
concentration and duration of exposure [30]. It has long
been discussed that this cytotoxicity of organotin com-
pounds might be the result of a massive alteration of the
intracellular calcium concentration [Ca2+]i. Various investi-
gationsdemonstratedanincreaseof[Ca2+]i afterexposureto
a variety of trialkytins, and this eﬀect should be responsible
for their cytotoxicity, immunotoxicity, and neurotoxicity not
only in mammalian [14, 17, 30–32] but also in ﬁsh cell
systems [22]. But more and more evidence has been supplied
that alteration of [Ca2+]i is not the major event in the
nonacute cytotoxic scenario [43, 44]. Numerous studies have
been carried out during the last two decades indicating the
induction of apoptosis in various biological systems without
elucidating the starting point of the involved molecular
mechanism [14, 17–25, 27, 28, 36]. As early as in 2001,
the ﬁrst publication demonstrated a possible involvement
of the death receptors [38], and this was conﬁrmed a
few years later [37]. Nevertheless, recently published data
connect developmental abnormalities of ﬁsh larvae with the
induction of apoptosis on the level of caspase 3 [45], and
the initiating molecular mechanism by which TBT induces
apoptosis is not described. Thus, this study was carried out
to enlighten the mechanism in more detail.
There exist two diﬀerent pathways for apoptosis that
can be distinguished from each other, the extrinsic and the
intrinsic pathway [46]. The intrinsic pathway is dependent
from proapoptotic events on the level of the mitochondria
and is mostly aﬀected by environmental chemicals or stress
factors. Thus, it seems to be obvious that toxic substances
such as TBT exert their eﬀect on mitochondria. A multitude
of studies have shown that diﬀerent parameters of mito-
chondria were altered after treatment of cells with TBT [18,
32, 37]. Nonetheless, the induction of apoptosis could not
be explained suﬃciently by all these examinations because
mitochondria-independent apoptosis has been described as
well [37, 47] and inhibition of the intrinsic pathway by bcl-
2 overexpression protects only type II cells but not type I
cells from apoptosis although the mitochondrial membrane
potential ΔΨm is still high [48]. Moreover, it has been
publishedearlierthatvariousmetalcompoundsmayactivate
the extrinsic apoptotic pathway [37–39, 49]. A closer look
on the formation of the “death-inducing signalling complex”
(DISC) reveals its formation within 1 to 3h after treatment
with TBT (Figure 5). Normally, in Jurkat T cells, the DISC
consists out of the Fas-receptor molecules to which the
adaptor molecules FADD and initiator caspase-8 are bound.
But the caspase-8-deﬁcient Jurkat cells showed no or only
little reduction in apoptosis after TBT treatment, and solely
FADD deﬁciency decreases substantially the apoptotic cell
number although not all. So we looked for other elements
as possible constituents of the DISC. As it was published by
several groups that not only caspase-8 but also caspase-10
can be recruited to death receptors [50, 51], Apo2L/TRAIL
is able to activate both initiator caspases, and caspase-10 isJournal of Toxicology 5
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Figure 3: Caspase-10 inhibition prevents TBT-induced apoptosis in all variants of Jurkat A3 cells. Jurkat cells were pretreated with the
caspase-10 inhibitor AEVD (8.7μM, 1h) before TBT was added (1μM, 4h). Then, the cells were stained with annexin V-FITC/PI to separate
apoptoticcellsfromnecroticandviablecellsbyﬂowcytometry.ThehistogramsshowtheﬂuorescenceintensityofPI-negativeonly(compare
lower two quadrants in Figures 1(g) and 1(h)). Numbers given for TBT-treated samples represent the percentage of total cells counted
(10000). Presented are the histograms of all three Jurkat A3 variants.
described as important caspase in HCT 116 colon carcinoma
cells [52], we analysed the DISC formation in more detail.
As mentioned above, caspase-10 could be found in the
DISC and is co-precipitated by anti-TRAIL-R2 antibody.
These results were conﬁrmed by measuring various caspase
activities in lysates using the substrates IETD-pNA (caspase-
8), AEVD-pNA (caspase-10), and DEVD-pNA (caspase-3),
respectively. In lysates of TBT-treated cells, all caspases have
been found to be active (data not shown). Thus, TBT leads
not only to unspeciﬁc cleavage of caspases but directly to
their activation.
Because caspase-8-deﬁcient Jurkat cells express lower
amounts of caspase-10 compared to their parental cell line,
these cells might be somewhat less sensitive to TBT as dem-
onstrated here (Figure 3). But determination of all apoptotic
markers revealed a nearly unchanged sensitivity to TBT of
Jurkat cells lacking caspase-8 when treatment is prolonged
to a minimum of 4h. Another set of experiments focuses on
caspases in more detail. Overall inhibition of caspases with
zVAD-fmk, an unspeciﬁc inhibitor of all cellular caspases,
inhibitstotallyTBT-inducedapoptosisinhumanneutrophils
[19]a sw e l la si nJ u r k a tc e l l s( d a t an o ts h o w n ) .As t r o n g
evidence for a speciﬁc role of the initiator caspase-10 comes
from our experiments with its speciﬁc inhibitor zAEVD-
fmk. While Fas-ligand-induced apoptosis is only slightly
prevented after pre-incubation of the cells with AEVD
(Figure 6), TBT-treatment has no eﬀect at all, when caspase-
10 was inactivated before. Nevertheless, Kischkel and co-
workers [50] described FADD as an obligatory adaptor for
both initiator caspases to TRAIL receptor; thus, we expected
the FADD-deﬁcient cells to be protected against TBT-
induced apoptosis. But this is the case only for lower con-
centrations of TBT up to 1μM. In this case, the prevention of
FADD-deﬁcient cells is apparent (Figure 2), whereas slightly
higher concentrations (1.5μM) overcome this protective
eﬀect. This might be due to the fact that these higher
concentrations directly aﬀect, on the one hand, the intrinsic
machinery of apoptosis or, on the other hand, TBT might be6 Journal of Toxicology
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Figure 4: Caspase activity induced by TBT treatment in Jurkat A3 cells. Jurkat cells were pretreated with the caspase-10 inhibitor AEVD
(8.7μM, 1h) before TBT was added (1μM, 4h). At the end of the treatment, FAM-VAD-fmk was added as a caspase substrate that
exhibits ﬂuorescence after cleavage. Cells were incubated for further 60min, counterstained with propidium iodide (red ﬂuorescence), and
intracellular ﬂuorescence intensity was analysed by microscopy. C: vehicle-treated control cells; TBT: 1μM TBT; TBT + AEVD: pretreated
with zAEVD-fmk for 1h and 1μM TBT for further 4h.
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Figure 5: TBT induces recruitment of caspase-8 and caspase-10 by TRAIL-R2. Jurkat A3 wt cells were treated with or without TBT for
3h before cells were lysed and immunoprecipitation (IP) was carried out with anti-TRAIL-R2 antibody. Initiator caspase-8 and caspase-10
were detected by western blotting (WB) in the precipitates (a). Both antibodies recognise full length procaspases and the processed subunits.
Asterisk indicates an unspeciﬁc band. Caspase-10 was further investigated in all three cell lines after IP with anti-TRAIL-R2 antibody (b).
After 2 or 3h of incubation with TBT, cells were analysed by IP/WB. In all three cell lines, the amount of procaspase-10 and/or its cleavage
productsincreaseovertimeintheprecipitate.LoadingcontrolforTRAIL-R2isshownbelow.Arrowsandnumbersgivethemolecularweight
of procaspases and cleaved subunits. Both parts of the western blot (upper part containing the procaspase-10, lower part with the cleavage
products) are diﬀerentially exposed to visualize the weak bands of the cleavage products.
able to activate directly caspases as has been demonstrated
earlier[36,47].Another evidencefor caspase-10 dependency
with no or only less involvement of FADD-adaptor protein
hasbeendescribedrecentlyforanotherchemicalbutwiththe
same set of Jurkat cells [53]. This group found the same total
inhibition of all eﬀects by the caspase-10 inhibitor zAEVD-
fmk and no reduction in caspase-8-deﬁcient cells. Moreover,
FADD recruitment was not involved because the FADD-
deﬁcientJurkatcellsexhibitedDNAfragmentationandother
signsofapoptosis;thus,theseresultsareobviouslycongruent
with the data presented here.
Furthermore, it has been published lately that caspase-
10 may cleave speciﬁc substrates, as the proapoptotic protein
BID, without being cleaved before into its active subunits
[54] .T h i sm a yb et h er e a s o nw h yt y p eI Ic e l l sa r em o r e
sensitive to bcl-2 overexpression than type I cells, as type
II cells are dependent on BID cleavage and the activation of
the mitochondrial pathway. In our hands, the type I cell lineJournal of Toxicology 7
Figure 6: Caspase-10 inhibition prevents all TBT-induced apop-
totic eﬀects in Jurkat A3 cells. Jurkat A3 parental and the two
deﬁcient cell lines were analysed as shown in Figure 2 except
the pretreatment was accomplished with zAEVD-fmk. Jurkat A3
wt cells were treated with 1μM TBT or Fas-ligand (Fas-L) as
positive control for 4h, and the deﬁcient cell lines were treated
with TBT only before proteins were separated on SDS-gels and
immunoblotted. A second set of samples was preincubated for 1h
with the caspase-10 inhibitor AEVD (8.7μM) before TBT or Fas-L
were added. Additionally, DNA fragmentation was recorded from
the same samples after agarose gel electrophoresis.
SKW has a higher level of caspase-10 expression, and this is
cleaved at the DISC in both variants, the wild type as well as
in the bcl-2 overexpressing line (data not shown).
The question to what extent the extrinsic or the intrinsic
pathway is responsible for the TBT-induced apoptosis in
the absence of a functional FADD adaptor protein can
be answered by the concentrations of TBT used within
the experiments. Lower concentrations not disturbing the
lysosomal or mitochondrial systems are more or less totally
dependent on the formation of an activated DISC, whereas
higher concentrations overcome this mechanism and stress
the intracellular machinery via lysosomes or/and mitochon-
dria leading to caspase-independent responses [55–57]. The
here described results indicate that TBT in principle activates
initiator caspase-10 leading to BID cleavage and activation
of the mitochondria inducing the downstream apoptotic
machinery (Figure 7).
Besides mammalian system cells from other species were
aﬀected by TBT as well. In trout blood cells, 1–5μMT B T
induces apoptosis within 1h [35], and, in gill tissue of the
mussel Mytilus galloprovincialis treated with 1μg/g bw TBT
(≈3μM), apoptosis could be detected after 24h incubation
[28]. The strongly discussed immunosuppressive properties
of TBT in vivo might be the consequence of speciﬁc induc-
tion of cell death in immunocompetent cells. Such a killing
of lymphocytes by TBT can be observed as a loss in thymus
weight or thymus atrophy [29, 58] that debilitates the im-
mune function of animals, making them vulnerable to infec-
tious diseases [59–63].
On the background of these ﬁndings, the deadline for
banning TBT must be possibly reconsidered as not only sea
snails but also open water mammals and humans might be
aﬀected and new regulatory strategies have to be discussed
independent from market forces [64]. Whereas the Interna-
tional Maritime Organisation (IMO) has banned TBT since
2008, the European Commission has forbidden its use “after
1st of July 2010 in articles where the concentration in the
article, or part thereof, is greater than the equivalent of 0.1%
by weight of tin,” but “articles treated with such biocides may
still be imported into the Community” [65].
4.MaterialsandMethods
4.1. Materials. All cell culture reagents were purchased from
Life Technologies (Eggenstein, Germany), petri dishes and
multiwell plates were obtained from Nunc (Wiesbaden, Ger-
many). Annexin-FITC is from BD Pharmingen (Heidelberg,
Germany), PI and Hoechst 33342 from Sigma (Deisenhofen,
Germany), and the inhibitors of caspase-10 (zAEVD-fmk;
FMK009), caspase-9 (zLEHD-fmk; FMK008), and caspase-
3 (zDEVD-fmk; FMK004) were from R&D Systems (Wies-
baden, Germany).
The primary antibodies anti-caspase-6 (Cat no. 9762),
anti-caspase-7 (Cat no. 9492) and anti-caspase-9 (Cat no.
9502) were purchased from Cell Signaling Technology
(Frankfurt, Germany), anti-caspase-3 (Cat no. C31720),
and anti-caspase-8 (Cat no. 551242 clone 3-1-9) from BD
Pharmingen (Heidelberg, Germany), anti-caspase-10/a (Cat
no. M059-3) from MoBiTec (MBL) (G¨ ottingen, Germany),
anti-TRAIL-R2 (DR5) (Cat no. PC392) from Calbiochem
(Darmstadt,Germany),anti-BID(Catno.AF846)fromR&D
Systems (Wiesbaden, Germany), and anti-PARP (Cat no.
1835238) from Roche Biochemica (Mannheim, Germany).
As secondary reagents, we used: horseradish-peroxidase-
(HRP-) conjugated goat anti-mouse IgG1 (Cat no. P 0447)
from DakoCytomation (Glostrup, Denmark) and HRP-con-
jugateddonkeyanti-rabbit(Catno.NA934)fromAmersham
Biosciences (Freiburg, Germany).
4.2. Cell Cultures. The Jurkat cell line A3 as well as the
FADDandcaspase-8-deﬁcientcelllineswerekindlyprovided
by J. Blenis (Harvard Medical School, Boston, USA) and
were maintained in RPMI 1640 supplemented with 10% FCS
and 1mM HEPES. The cultures were grown with 100U/mL
penicillin and 100μg/mL streptomycin in a humidiﬁed at-
mosphere containing 5% CO2 at 37◦C. During experiments,
10mM glucose were additionally included in the incubation
medium.8 Journal of Toxicology
Figure 7: Proposed scheme of TBT-induced apoptosis in Jurkat cells. TBT activates caspase-10 upstream of mitochondria which leads to
BID cleavage, and activation of the mitochondria. Downstream caspases were then cleaved and the caspase-cascade is provoked. Caspase-8
deﬁciency cannot prevent apoptosis, but inhibition of caspase-10 (AEVD) or inhibition of the two important caspases downstream of the
mitochondria, caspase-9 and caspase-3 (LEHD and DEVD), totally suppress cell death.
4.3. Methods
4.3.1. Treatment of the Cells. For induction of apoptosis, 2 ×
106 cells per mL medium were incubated with 1μL/mL of
a 1mM stock solution of TBT (Merck) in ethanol to give the
ﬁnalconcentrationof1μM.Asapositivecontrol,100ngFas-
ligand plus 1μg enhancer (Alexis, San Diego, USA) per mL
incubation medium were used. All controls were incubatedJournal of Toxicology 9
with the same amount of vehicle (1μL ethanol/mL) to ex-
c l u d es i d ee ﬀects of the solvent.
4.3.2. DNA Fragmentation. Apoptotic DNA fragments were
isolated according to the following procedure. 2 × 106 were
disrupted in 500μLl y s i sb u ﬀer (20mM EDTA, 1% NP 40,
50mM Tris/HCl, pH 7.5). After centrifugation at 1600g
for 5min, supernatants containing the apoptotic DNA were
transferred into Eppendorf tubes. After addition of 1% SDS,
samples were treated for 2h with RNAse-A (5μg/μL) at
56◦C and subsequently for further 2h with proteinase K
(2.5μg/μL). The DNA was precipitated by the addition of
50μL of 10M ammoniumacetate and 250μL ice-cold etha-
nol, stored overnight at −20◦C followed by centrifugation.
The pellet was resuspended in 25μLo fT E - b u ﬀer (10mM
Tris/HCl, 1mM EDTA, pH 8.0), and the DNA-fragments
were analysed by agarose gel electrophoresis (1.8% agarose
containing ethidium bromide as DNA stain), and pictures
were taken with a MWG Gel documentation system.
4.3.3. Caspa-Tag Assay. The assay was carried out as de-
scribed by the manufacturer (Intergen, Heidelberg, Ger-
many). From each treated sample, 150μL containing 3 ×
105 cells were washed with fresh medium and 10μL of 30x
solution of the caspase substrate FAM-VAD-fmk were added
to give the ﬁnal concentration of 10μM. The mixture was
further incubated for 1h in an incubator at 37◦C. Then,
1mL of washing solution was added, the suspension was
centrifuged at 400g for 5min at room temperature. The
resultingcellpelletwaswashedoncewithwashingbuﬀerand
ﬁnally resuspended in 400μL washing buﬀer including 1μL
PI as counterstain for necrosis. Cells were left for 15min on
ice, and then the microscopic pictures were taken.
4.3.4. Immunoprecipitation. TRAIL-associated caspase-10
and caspase-8 were immunoprecipitated as follows: 107
cells (2 × 106/mL) were treated with 1μM TBT and then
lysed in 500μLc e l ll y s i sb u ﬀer (30mM Tris/HCl, pH
7.5, 150mM NaCl, 1mM phenylmethylsulfonyl ﬂuoride,
10μg/mL aprotinin and 10μg/mL leupeptin, 1% Triton and
10% glycerol). The lysates were centrifuged at 14000g for
10min at 4◦C. The supernatants were then incubated for 4h
with protein A-Sepharose (Sigma, Deisenhofen, Germany)
and 1.5μg anti-TRAIL-R2. The beads were centrifuged at
7000g for 6min at 4◦C, washed once with the same amount
of lysis buﬀer, and centrifuged again. After having removed
the supernatants carefully, the pellets were resuspended in
100μLe l e c t r o p h o r e s i sb u ﬀer and 15μLo fe a c hs a m p l ew e r e
analysed by SDS-gel electrophoresis and western blotting.
4.3.5. Apoptosis Assays. Apoptotic and necrotic cells were
determined either microscopically or by ﬂow cytometry
using recombinant annexin V conjugated to FITC and
propidium iodide. The determination of apoptosis is based
on the binding of annexin V-FITC on the phosphatidylserine
exposed at the surface of apoptotic cells. Necroses were
determined by staining with the membrane impermeable
DNA-intercalating dye PI. For the assay, 1 × 106 cells were
pelleted at 1500g and resuspended in 100μL binding buﬀer
(10mM HEPES, pH 7.4, 140mM NaCl and 5mM CaCl2)
containing 5μL annexin V-FITC and 100ng PI. After 15min
of incubation at 4◦C in the dark, cells were diluted in
400μL binding buﬀer and immediately analysed by ﬂow
cytometry.Fluorescencewasanalysedat530 ±14nm(FITC)
and 610 ± 10nm (PI) and quantiﬁed with the CELLQuest
Prosoftware (BD, Heidelberg, Germany).
For microscopic assessment of apoptosis and necrosis, 6
× 104 cells were diluted 1:1 with 2x binding buﬀer, con-
taining 1μL annexin V-FITC and 3ng PI. After 15min of
incubation in the dark, cells were analysed with a 63x oil
objective and a Zeiss Axiovert S100 microscope (Carl Zeiss
GmbH, Jena, Germany), connected to a Hamamatsu CCD
Camera (C4880-80). Fluorescence and diﬀerential interfer-
ence contrast pictures were taken using an automation pro-
cedure and merged using Openlab software (Improvision,
Coventry, UK).
Chromatin condensation was determined after staining
of the cells with Hoechst 33342. In short, after treatment, 1 ×
106 cells were washed with phosphate-buﬀered saline (PBS)
incubatedwithaﬁnalconcentrationof10μMHoechst33342
for 10min, washed again with PBS to reduce background
ﬂuorescence, and ﬁnally visualised with the same system
describedabovewithexcitationat364 ±15nmandemission
at 460 ± 10nm.
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